Keith B. Glaser
Cancer Research R47J-AP9
Abbott Laboratories
Abbott Park
IL 60064-6121
USA
Name/email consistency: high
- A renaissance in marine pharmacology: from preclinical curiosity to clinical reality. Glaser, K.B., Mayer, A.M. Biochem. Pharmacol. (2009)
- ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia. Shankar, D.B., Li, J., Tapang, P., Owen McCall, J., Pease, L.J., Dai, Y., Wei, R.Q., Albert, D.H., Bouska, J.J., Osterling, D.J., Guo, J., Marcotte, P.A., Johnson, E.F., Soni, N., Hartandi, K., Michaelides, M.R., Davidsen, S.K., Priceman, S.J., Chang, J.C., Rhodes, K., Shah, N., Moore, T.B., Sakamoto, K.M., Glaser, K.B. Blood (2007)
- HDAC inhibitors: clinical update and mechanism-based potential. Glaser, K.B. Biochem. Pharmacol. (2007)
- Differential protein acetylation induced by novel histone deacetylase inhibitors. Glaser, K.B., Li, J., Pease, L.J., Staver, M.J., Marcotte, P.A., Guo, J., Frey, R.R., Garland, R.B., Heyman, H.R., Wada, C.K., Vasudevan, A., Michaelides, M.R., Davidsen, S.K., Curtin, M.L. Biochem. Biophys. Res. Commun. (2004)
- Role of class I and class II histone deacetylases in carcinoma cells using siRNA. Glaser, K.B., Li, J., Staver, M.J., Wei, R.Q., Albert, D.H., Davidsen, S.K. Biochem. Biophys. Res. Commun. (2003)
- Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylase. Glaser, K.B., Li, J., Aakre, M.E., Morgan, D.W., Sheppard, G., Stewart, K.D., Pollock, J., Lee, P., O'Connor, C.Z., Anderson, S.N., Mussatto, D.J., Wegner, C.W., Moses, H.L. Mol. Cancer Ther. (2002)